DGAP-CMS: BASF SE: Release of a capital market information
2022. augusztus 01., hétfő, 10:49
Disclosure according to art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) no. 596/2014 in connection with art. 2 para. 2 and para. 3 of the Delegated Regulation (EU) no. 2016/1052
Share buyback – 29th Interim Report
Ludwigshafen – August 1, 2022 – In the period from July 25, 2022 until and including July 29, 2022 a number of 5,000 shares were bought back within the framework of the share buyback program of BASF SE; on January 11, 2022, BASF SE disclosed pursuant to art. 5 para. 1 lit. a) of the Regulation (EU) no. 596/2014 and art. 2 para. 1 of the Delegated Regulation (EU) no. 2016/1052 the start of the share buyback on January 11, 2022.
The number of shares bought back daily and the daily volume-weighted average share prices are as follows:
The transactions in a detailed form are published on the website of BASF SE at www.basf.com/sharebuyback.
The total volume of shares which have been bought back within the framework of the share buyback program in the period from January 11, 2022 until and including July 29, 2022 amounts to a number of 20,295,254 shares.
The purchase of the shares of BASF SE is carried out by a bank that has been commissioned by BASF SE; the shares are purchased on the electronic trading platform of the Frankfurt Stock Exchange (Xetra).
Contact Dr. Stefanie Wettberg BASF Investor Relations +49 621-60-48002
|
Language: | English |
Company: | BASF SE |
Carl-Bosch-Straße 38 | |
67056 Ludwigshafen | |
Germany | |
Internet: | www.basf.com |
End of News | DGAP News Service |
1410125 01.08.2022
Közzétételek - archívum
-
» Laxxon Medical to Participate in the BIO CEO & Investor Conference
[2023.02.02. 20:15]
-
» PJSC Magnitogorsk Iron and Steel Works: MMK notifies on additional extension of consent solicitation process
[2022.06.30. 13:00]
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]